We're raising $40MM (a $10MM post-seed plus a $30MM Series A) to take Lami-Pro™ from IND-enabling studies into first-in-human trials. We welcome qualified investors, strategic partners, and media.
Qualified investors and partners — tell us a little about you and we'll be in touch.